107 related articles for article (PubMed ID: 11517934)
1. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer.
Zore I; Krasovec M; Cimerman N; Kuhelj R; Werle B; Nielsen HJ; Brünner N; Kos J
Biol Chem; 2001 May; 382(5):805-10. PubMed ID: 11517934
[TBL] [Abstract][Full Text] [Related]
2. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
[TBL] [Abstract][Full Text] [Related]
3. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.
Nishikawa H; Ozaki Y; Nakanishi T; Blomgren K; Tada T; Arakawa A; Suzumori K
Gynecol Oncol; 2004 Mar; 92(3):881-6. PubMed ID: 14984956
[TBL] [Abstract][Full Text] [Related]
4. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1997; 44(4):219-39. PubMed ID: 9473776
[TBL] [Abstract][Full Text] [Related]
6. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
Tumminello FM; Flandina C; Crescimanno M; Leto G
Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092
[TBL] [Abstract][Full Text] [Related]
7. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
Schweiger A; Staib A; Werle B; Krasovec M; Lah TT; Ebert W; Turk V; Kos J
Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746
[TBL] [Abstract][Full Text] [Related]
8. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients.
Lüthgens K; Ebert W; Trefz G; Gabrijelcic D; Turk V; Lah T
Cancer Detect Prev; 1993; 17(3):387-97. PubMed ID: 8402725
[TBL] [Abstract][Full Text] [Related]
10. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
11. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
Werle B; Schanzenbächer U; Lah TT; Ebert E; Jülke B; Ebert W; Fiehn W; Kayser K; Spiess E; Abrahamson M; Kos J
Oncol Rep; 2006 Oct; 16(4):647-55. PubMed ID: 16969475
[TBL] [Abstract][Full Text] [Related]
12. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
13. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis.
Kos J; Sekirnik A; Kopitar G; Cimerman N; Kayser K; Stremmer A; Fiehn W; Werle B
Br J Cancer; 2001 Oct; 85(8):1193-200. PubMed ID: 11710834
[TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C in patients with head and neck carcinoma.
Strojan P; Svetic B; Smid L; Kos J
Clin Chim Acta; 2004 Jun; 344(1-2):155-61. PubMed ID: 15149884
[TBL] [Abstract][Full Text] [Related]
16. [Cystatin C as a marker of glomerular filtration rate].
Piwowar A; Warwas M
Postepy Hig Med Dosw; 2001; 55(5):687-98. PubMed ID: 11795203
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma.
Mulaomerović A; Halilbasić A; Cickusić E; Zavasnik-Bergant T; Begić L; Kos J
Cancer Lett; 2007 Apr; 248(2):192-7. PubMed ID: 16945481
[TBL] [Abstract][Full Text] [Related]
18. Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease.
Tsai HT; Wang PH; Tee YT; Lin LY; Hsieh YS; Yang SF
Fertil Steril; 2009 Feb; 91(2):549-55. PubMed ID: 18314113
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
20. Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm.
Gacko M; Chyczewski L; Chrostek L
Pol J Pathol; 1999; 50(2):83-6. PubMed ID: 10481531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
